SCHEMBL6204472

SCHEMBL6204472

O=C1[N]c2cc(Nc3ccc(F)cc3F)c(C3CCNC3)cc2N1

nearest known ligand 0.35

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
MPO P05164 1/20 0.35
ALDH1A1 P00352 1/20 0.34
SRC P12931 2/20 0.33
BTK Q06187 2/20 0.33
LYN P07948 1/20 0.33
MAPK9 P45984 1/20 0.33
SLC6A2 P23975 2/20 0.33
SLC6A4 P31645 2/20 0.33
SLC6A3 Q01959 2/20 0.33
HTR1A P08908 1/20 0.33
TP53 P04637 1/20 0.32
DPP4 P27487 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C19 P33261 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6160094 0.73 TLR9 (0.36) SLC6A2SLC6A4SLC6A3HTR1A
SCHEMBL29904548 0.68 CHRNB2 (0.51) MPOSLC6A2SLC6A4SLC6A3HTR1A
SCHEMBL20438926 0.68 CHRNB2 (0.51) MPOSLC6A2SLC6A4SLC6A3HTR1A
SCHEMBL1822160 0.68 CHRNB2 (0.51) MPOSLC6A2SLC6A4SLC6A3HTR1A
Hydrochloric Acid SCHEMBL29051178 0.67 CHRNB2 (0.50) MPOSLC6A2SLC6A4SLC6A3HTR1A
SCHEMBL4301470 0.66 MAPT (0.34) SLC6A2SLC6A4SLC6A3HTR1A
SCHEMBL19995723 0.66 CHRNB2 (0.51) MPOSLC6A2SLC6A4SLC6A3HTR1A
SCHEMBL27913713 0.66 CHRNB2 (0.51) MPOSLC6A2SLC6A4SLC6A3HTR1A
SCHEMBL4977286 0.64 HTR6 (0.38) MPOSLC6A2SLC6A4SLC6A3HTR1A
SCHEMBL4750469 0.64 CA1 (0.40) CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1539708-A1 BENZIMIDAZOLONES AND THEIR USE AS CYTOKINE INHIBITORS BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) 2005-06-15 EP disclosed
WO-2004024699-A1 BENZIMIDAZOLONES AND THEIR USE AS CYTOKINE INHIBITORS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2004-03-25 WO disclosed